ECIA ENCISION INC
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 930775 · Fiscal year ends 03/31
Financial factors as of 2025-09-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-3.0%
TTM net income YoY45.0%
TTM EPS YoY50.0%
Revenue 3-yr CAGR-5.3%
Net income 3-yr CAGR—
Margins
Gross margin52.6%
Operating margin-5.1%
Net margin-6.0%
FCF margin-8.6%
EBITDA margin-3.7%
Returns
ROE-21.4%
ROA-10.1%
ROIC (approx.)-15.5%
Asset turnover1.66x
Leverage & solvency
Liabilities / assets54.0%
Debt / equity0.00x
Current ratio2.28x
Interest coverage-5.69x
Cash quality & payout
Operating cash flow / net income1.29x
Accruals ratio2.9%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-03-31 | FY20242024-03-31 | FY20232023-03-31 | FY20222022-03-31 | FY20212021-03-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $6.56M | $6.59M | $7.35M | $7.67M | $7.54M |
| Cost of revenue | $3.04M | $3.45M | $3.32M | $3.88M | $3.63M |
| Gross profit | $3.51M | $3.14M | $4.03M | $3.79M | $3.91M |
| R&D expense | $593,152 | $621,894 | $816,119 | $918,155 | $569,542 |
| SG&A expense | $1.40M | $1.52M | $1.49M | $1.38M | $1.38M |
| Operating income | -$171,980 | -$640,783 | -$302,797 | -$594,934 | -$61,641 |
| Interest expense | $43,723 | $62,373 | $19,529 | $7,224 | $87,127 |
| Pretax income | -$220,198 | -$691,783 | -$323,945 | -$65,594 | $584,734 |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$220,198 | -$691,783 | -$323,945 | -$65,594 | $584,734 |
| EBITDA | -$90,587 | -$555,565 | -$215,891 | -$481,464 | $27,314 |
| EPS (basic) | -0.02 | -0.06 | -0.03 | -0.01 | 0.05 |
| EPS (diluted) | -0.02 | -0.06 | -0.03 | -0.01 | 0.05 |
| Weighted avg. shares (diluted) | 11.88M | 11.77M | 11.76M | 11.63M | 11.77M |
| Balance sheet | |||||
| Cash & equivalents | $257,433 | $42,509 | $188,966 | $949,645 | $1.47M |
| Receivables | $786,471 | $891,129 | $920,721 | $947,623 | $1.02M |
| Inventory | $1.48M | $1.40M | $1.90M | $1.58M | $1.45M |
| Current assets | $2.61M | $2.43M | $3.12M | $3.60M | $4.10M |
| PP&E, net | $244,757 | $254,004 | $303,276 | $189,297 | $265,717 |
| Intangibles | $171,890 | $164,010 | $163,133 | $180,719 | $213,368 |
| Total assets | $3.67M | $3.81M | $4.13M | $4.79M | $5.66M |
| Current liabilities | $1.58M | $1.07M | $1.13M | $1.28M | $1.18M |
| Short-term debt | — | — | $227,300 | — | $227,300 |
| Total liabilities | $2.02M | $1.98M | $1.64M | $2.05M | $2.86M |
| Shareholders' equity | $1.65M | $1.83M | $2.49M | $2.75M | $2.80M |
| Shares outstanding | 11.88M | 11.86M | 11.77M | 11.72M | 11.58M |
| Cash flow statement | |||||
| Operating cash flow | -$54,948 | $144,389 | -$861,485 | -$444,432 | $219,946 |
| Capital expenditure | $54,415 | $12,050 | $173,269 | $17,550 | $30,020 |
| Free cash flow | -$109,363 | $132,339 | -$1.03M | -$461,982 | $189,926 |
| Investing cash flow | -$80,025 | -$36,823 | -$183,299 | -$35,401 | -$45,186 |
| Financing cash flow | $349,897 | -$254,023 | $284,105 | -$44,861 | $914,447 |
| Depreciation & amortization | $81,393 | $85,218 | $86,906 | $113,470 | $88,955 |
| Stock-based compensation | $46,001 | $53,552 | $51,892 | $40,853 | $33,354 |
Free plan shows the latest 5 periods; Pro shows all 15 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.